Mondor's disease after implant-based breast reconstruction. Report of three cases and review of the literature.

Mondor’s disease (MD) is a benign condition consisting of trombophlebitis and consequent phlebosclerosis of super- ficial veins of the anterolateral thoracic wall, and typically presents as a superficial vertical band of two-to-five mm in diameter descending from the inframammary fold to the inguinal region. MD of the breast is generally related to trauma or surgery, and normally develops with a delay of three-to-six weeks.1 It has been described after breast reduction and implant-based breast augmentation.1,2 An incidence up to 12% has been reported in breast cancer patients.